Study of the effect of chronic kidney disease on the incidence of cardiovascular events in a native Spanish population

被引:0
|
作者
Cancho, Barbara [1 ]
Robles, Nicolas Roberto [1 ,2 ,3 ]
Felix-Redondo, Francisco Javier [4 ]
Lozano, Luis [5 ]
Fernandez-Berges, Daniel [6 ,7 ,8 ]
机构
[1] Hosp Univ Badajoz, Badajoz, Spain
[2] Univ Salamanca, Fac Med, Catedra Riesgo Vasc, Salamanca, Spain
[3] Inst Salud Carlos III RENINRED, Red Invest Renal, Madrid, Spain
[4] Ctr Salud Villanueva Serena Norte, Villanueva Serena, Badajoz, Spain
[5] Ctr Salud Merida, Badajoz, Spain
[6] Programa Invest Enfermedades Cardiovasc, Unidad Invest Don BenitoVillanueva Serena, Villanueva Serena, Badajoz, Spain
[7] Grp Invest Multidisciplinar Extremadura, Badajoz, Spain
[8] Inst Univ Invest Biosanitaria Extremadura IN, Badajoz, Spain
来源
MEDICINA CLINICA | 2021年 / 157卷 / 12期
关键词
Chronic kidney disease; Urinary albumin excretion; Cardiovascular disease; GLOMERULAR-FILTRATION-RATE; URINARY ALBUMIN EXCRETION; RISK; PREVALENCE; OUTCOMES; SPAIN; EPIDEMIOLOGY; DYSFUNCTION; MORTALITY; DEATH;
D O I
10.1016/j.medcli.2020.10.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To evaluate the relationship between chronic kidney disease and the patient's cardiovascular risk measured through the incidence of major adverse cardiovascular events in a sample of Spanish population. Design and methods: The sample consisted of 2,668 subjects. Mean age was 50.6 +/- 14.5 years and 54.6% were female. In all, 3.5% of subjects had a glomerular filtration rate (GFR) below 60 ml/min and 4.3% a urinary albumin excretion (UAE) above 30 mg/g. GFR was estimated from serum creatinine using the CKD-EPI equation. UAE was measured in first morning urine sample as mg/g of creatinine. We examined the multivariable association between the estimated GFR and the risks of cardiovascular events and death. The median follow-up was 81 (75-89) months. Results: In CKD patients the hazard ratio (HR) was 1.36 (95% CI 0.97-1.91) (P = .079) for cardiovascu-lar events and 1.62 (95% CI 0.53-4.91) (P = .396) for cardiovascular mortality. Increased UAE was also associated with higher cardiovascular risk (HR 2.38; 95% CI 1.51-3.74; P < .001) as well as increased car-diovascular mortality (HR 4.78; 95% CI 2.50-9.11; P < .001). For patients with UAE between 30 and 300 mg/g HR for cardiovascular events was 2.09 (95% CI 1.34-3.50; P = .005) and 3.80 (95% CI 1.81-7.96; P < .001) for cardiovascular mortality. Conclusions: An independent association was found between reduced GFR and cardiovascular event inci-dence and mortality. Increased UAE showed a higher prognostic value than decreased GFR. Our findings highlight the clinical and public health importance of routinely measuring UAE. (C) 2021 Elsevier Espan tilde a, S.L.U. All rights reserved.
引用
收藏
页码:569 / 574
页数:6
相关论文
共 50 条
  • [1] A PROSPECTIVE STUDY OF THE EFFECT OF CHRONIC KIDNEY DISEASE ON THE INCIDENCE OF CARDIOVASCULAR EVENTS IN A NATIVE SPANISH POPULATION
    Robles Perez-Monteoliva, N. R.
    Cancho, B.
    Felix, F.
    Lozano, L.
    Fernandez-Berges, D.
    JOURNAL OF HYPERTENSION, 2019, 37 : E132 - E132
  • [2] A PROSPECTIVE STUDY OF THE EFFECT OF CHRONIC KIDNEY DISEASE ON THE INCIDENCE OF CARDIOVASCULAR EVENTS IN A NATIVE SPANISH POPULATION
    Diaz-Campillejo, Rosa
    Roberto Robles, Nicolas
    Javier Felix, Francisco
    Lozano, Luis
    Fernandez-Berges, Daniel
    Cancho, Barbara
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [3] Incidence of cardiovascular events and mortality in Korean patients with chronic kidney disease
    Ryu, Hyunjin
    Kim, Jayoun
    Kang, Eunjeong
    Hong, Yeji
    Chae, Dong-Wan
    Choi, Kyu Hun
    Han, Seung Hyeok
    Yoo, Tae Hyun
    Lee, Kyubeck
    Kim, Yong-Soo
    Chung, Wookyung
    Oh, Yun Kyu
    Kim, Soo Wan
    Kim, Yeong Hoon
    Sung, Su Ah
    Lee, Joongyub
    Park, Sue K.
    Ahn, Curie
    Oh, Kook-Hwan
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [4] Effect of pravastatin on cardiovascular events in people with chronic kidney disease
    Tonelli, M
    Isles, C
    Curhan, GC
    Tonkin, A
    Pfeffer, MA
    Shepherd, J
    Sacks, FM
    Furberg, C
    Cobbe, SM
    Simes, J
    Craven, T
    West, M
    CIRCULATION, 2004, 110 (12) : 1557 - 1563
  • [5] Cystatin C as a Predictor of Mortality and Cardiovascular Events in a Population with Chronic Kidney Disease
    Vigil, Ana
    Condes, Emilia
    Vigil, Luis
    Gallar, Paloma
    Oliet, Aniana
    Ortega, Olimpia
    Rodriguez, Isabel
    Ortiz, Milagros
    Herrero, Juan Carlos
    Mon, Carmen
    Cobo, Gabriela
    Jimenez, Juana
    INTERNATIONAL JOURNAL OF NEPHROLOGY, 2014, 2014
  • [6] Incidence of chronic kidney disease in general population, EPIRAN study
    Loos-Ayav, C.
    Briancon, S.
    Frimat, L.
    Andre, J. -L.
    Kessler, M.
    NEPHROLOGIE & THERAPEUTIQUE, 2009, 5 : S250 - S255
  • [7] Author Correction: Incidence of cardiovascular events and mortality in Korean patients with chronic kidney disease
    Hyunjin Ryu
    Jayoun Kim
    Eunjeong Kang
    Yeji Hong
    Dong‑Wan Chae
    Kyu Hun Choi
    Seung Hyeok Han
    Tae Hyun Yoo
    Kyubeck Lee
    Yong‑Soo Kim
    Wookyung Chung
    Yun Kyu Oh
    Soo Wan Kim
    Yeong Hoon Kim
    Su Ah Sung
    Joongyub Lee
    Sue K. Park
    Curie Ahn
    Kook‑Hwan Oh
    Scientific Reports, 11
  • [8] Incidence and risk of major adverse cardiovascular events in middle-aged patients with chronic kidney disease: a population-based cohort study
    Chen, Shiauyee
    Hsu, Wen-yen
    Lin, Yen-Nung
    Wang, Chien-Yung
    Wu, Chien-Hua
    Chang, Kwang-Hwa
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (07) : 1219 - 1227
  • [9] Incidence and risk of major adverse cardiovascular events in middle-aged patients with chronic kidney disease: a population-based cohort study
    Shiauyee Chen
    Wen-yen Hsu
    Yen-Nung Lin
    Chien-Yung Wang
    Chien-Hua Wu
    Kwang-Hwa Chang
    International Urology and Nephrology, 2019, 51 : 1219 - 1227
  • [10] MGUS incidence in a chronic kidney disease population
    Reid, Steven
    Cockwell, Paul
    Chandler, Katie
    Hutchison, Colin
    Mead, Graham
    Bradwell, Arthur
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 395 - 395